The impact on quality of life by converting the treatment of type 2 diabetic patients from conventional insulin regiment to oral treatment with pioglitazone

Greiner W, Hodek JM (2006) .

Conference Abstract | Published | English

No fulltext has been uploaded

Author
;
Publishing Year
ISSN
PUB-ID

Cite this

Greiner W, Hodek JM. The impact on quality of life by converting the treatment of type 2 diabetic patients from conventional insulin regiment to oral treatment with pioglitazone.
Greiner, W., & Hodek, J. M. (2006). The impact on quality of life by converting the treatment of type 2 diabetic patients from conventional insulin regiment to oral treatment with pioglitazone. Presented at the .
Greiner, W., and Hodek, J. M. (2006).“The impact on quality of life by converting the treatment of type 2 diabetic patients from conventional insulin regiment to oral treatment with pioglitazone”.
Greiner, W., & Hodek, J.M., 2006. The impact on quality of life by converting the treatment of type 2 diabetic patients from conventional insulin regiment to oral treatment with pioglitazone.
W. Greiner and J.M. Hodek, “The impact on quality of life by converting the treatment of type 2 diabetic patients from conventional insulin regiment to oral treatment with pioglitazone”, BLACKWELL PUBLISHING, 2006.
Greiner, W., Hodek, J.M.: The impact on quality of life by converting the treatment of type 2 diabetic patients from conventional insulin regiment to oral treatment with pioglitazone. (2006).
Greiner, Wolfgang, and Hodek, J. M. “The impact on quality of life by converting the treatment of type 2 diabetic patients from conventional insulin regiment to oral treatment with pioglitazone”., BLACKWELL PUBLISHING, 2006.
This data publication is cited in the following publications:
This publication cites the following data publications:

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Search this title in

Google Scholar